相关实验视频

Updated: Jun 27, 2025

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

对过度活跃膀的新兴疗法:临床前,I期和II期研究

Samantha Gibson¹, Pamela Ellsworth¹

¹Division of urology, University of Central Florida College of Medicine, Orlando, FL, USA.

Expert opinion on investigational drugs

|May 2, 2024

概括

针对新途径的研究药物为过活性膀 (OAB) 管理提供了潜在的替代方案. 这些新疗法旨在提高疗效和减少与OAB综合征目前治疗方法相比的副作用.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
药理学药理学是指药理学的学科.
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

过活性膀综合征 (OAB) 是一种普遍的疾病,影响生活质量,并带来巨大的经济成本.
目前对OAB的药理疗法经常面临由于效率不足和不良副作用的限制,阻碍了患者的持久性.
了解OAB病理生理学的进步揭示了离子通道,自主神经系统和酶的作用.

研究的目的:

审查目前对过度活跃膀的护理标准.
专注于临床前期和早期临床试验 (I期和II期) 的试验药物,用于OAB管理.
探索超越既定机制的新型治疗点.

主要方法:

使用PubMed和Cochrane数据库进行了全面的文献审查.
他们还审查了在美国注册的临床试验.
审查的重点是新兴候选药物及其潜在的作用机制.

主要成果:

目前的OAB疗法在有效性和耐受性方面存在局限性.
新兴的候选药物准了其他途径,包括离子通道和酶.
这些新的方法可能会提供更个性化,更有效的OAB管理策略.

结论:

针对OAB病理生理学的新途径,为开发改进的治疗方法提供了一个有希望的途径.
影响离子通道和酶的研究药物可能为现有的OAB疗法提供有价值的替代品.
通过解决这些替代途径,可以实现更为定制的OAB管理方法.

关键词:

它具有抗胆性抗胆性作用.这是一种β-激动剂,β-激动剂.酵素酶是一种酶.基因治疗的基因疗法过度活动的膀药理疗法是一种药理疗法.

更多相关视频

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

Published on: August 21, 2012

Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder

Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder

Published on: May 23, 2020

相关概念视频

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...